ENTA

Enanta Pharmaceuticals, Inc.

12.87 USD
-0.56 (-4.17%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Enanta Pharmaceuticals, Inc. stock is down -1.45% since 30 days ago. The next earnings date is Aug 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 11 June’s closed higher than May.

About Enanta Pharmaceuticals, Inc.

Enanta Pharmaceuticals, Inc. discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus.